
December 2021 Newsletter
As 2021 draws to a close, we at DigitalHealth.London have been reflecting on the events of the year, both in our organisation and across the digital health sector.
The latest news and blogs from DigitalHealth.London, our Accelerator and Launchpad companies, Digital Pioneer Fellows and the wider network.
As 2021 draws to a close, we at DigitalHealth.London have been reflecting on the events of the year, both in our organisation and across the digital health sector.
Last month, patientMpower, an alumnus of the DigitalHealth.London Accelerator, was recognised as the SME generating the greatest NHS benefit at the annual showcase event. Eamonn Costello, CEO of patientMpower, summarises the latest digital transformation projects they have been involved in.
DigitalHealth.London Senior Navigator Ruth Bradbury, reflects on her key learnings from a roundtable event featuring Phlo Digital Pharmacy, one of the companies she supported during the 2021/21 Accelerator cohort.
DigitalHealth.London Navigator and former refugee health nurse, Brett Hatfield, discusses the digital challenges faced by refugees migrants and the opportunities that exist for innovators to resolve these issues.
This month, we are delighted to share a summary of findings following our five-week conversation with NHS and social care staff, industry, patients and academics, entitled “Driving digital: Insights and foresights from the health and care ecosystem”. We also announced a new transatlantic partnership with the Cedars-Sinai Accelerator to support international adoption of the US and UK’s best health tech companies.
CW+ announced the launch of the Horizon Fellowship programme, to be delivered in partnership with DigitalHealth.London.
The DigitalHealth.London Accelerator announced a new transatlantic partnership with MassChallenge, one of the world’s top accelerator programmes, to support high-potential companies working to improve digital health in the US and UK.
Motilent’s product GIQuant®, provides a clinically validated, objective disease activity score for small bowel Crohn’s disease based on intestinal motility and has recently received FDA 510k clearance in the USA – the rollout of this technology will be in partnership with Nuance AI solutions.
Five Accelerator companies, GetUBetter, DrDoctor, Ampersand Health, Concentric Health and Patients Know Best were announced as winners of the NHSX Adoption fund.
Two alumni Accelerator companies and one alumni Launchpad company were revealed as winners of 2021 Health Tech Digital awards.
The DigitalHealth.London and Cedars-Sinai Accelerators, two of the world’s top Accelerator programmes, today announce their new partnership supporting international adoption of some of the US and UK’s best health tech companies.
Surrey Heartlands Clinical Commissioning Group has announced plans to extend the use of Inhealthcare remote monitoring technology to cover blood pressure monitoring.